• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌的分子病理学和生物标志物。

Molecular pathology and biomarkers of bladder cancer.

机构信息

The University of Texas M.D. Anderson Cancer Center, Division of Pathology & Laboratory Medicine, Houston, TX, USA.

出版信息

Cancer Biomark. 2010;9(1-6):159-76. doi: 10.3233/CBM-2011-0175.

DOI:10.3233/CBM-2011-0175
PMID:22112475
Abstract

Bladder cancer originates in the epithelial lining of the bladder's mucosa and develops in association with several habitual, industrial, and environmental risk factors via papillary and non-papillary pathways. In this chapter we review novel concepts concerning the molecular mechanisms of early field change in bladder neoplasia stemming from whole-organ genomic mapping studies. These mechanisms are discussed in the context of molecular pathogenesis of bladder cancer and in relation to treatment and biomarker-based detection strategies.

摘要

膀胱癌起源于膀胱黏膜的上皮衬里,并通过乳头状和非乳头状途径与几种习惯性、工业和环境风险因素相关发展。在本章中,我们回顾了源于全器官基因组图谱研究的有关膀胱癌早期领域变化的分子机制的新观念。这些机制在膀胱癌的分子发病机制的背景下进行讨论,并与治疗和基于生物标志物的检测策略相关。

相似文献

1
Molecular pathology and biomarkers of bladder cancer.膀胱癌的分子病理学和生物标志物。
Cancer Biomark. 2010;9(1-6):159-76. doi: 10.3233/CBM-2011-0175.
2
The origins of bladder cancer.膀胱癌的起源。
Lab Invest. 2008 Jul;88(7):686-93. doi: 10.1038/labinvest.2008.48. Epub 2008 May 12.
3
Therapeutic opportunities in the intrinsic subtypes of muscle-invasive bladder cancer.肌层浸润性膀胱癌内在亚型的治疗机会。
Hematol Oncol Clin North Am. 2015 Apr;29(2):377-94, x-xi. doi: 10.1016/j.hoc.2014.11.003.
4
Emerging Bladder Cancer Biomarkers and Targets of Therapy.新兴的膀胱癌生物标志物与治疗靶点
Urol Clin North Am. 2016 Feb;43(1):63-76. doi: 10.1016/j.ucl.2015.08.006.
5
Systematic screening of protein-coding gene expression identified HMMR as a potential independent indicator of unfavorable survival in patients with papillary muscle-invasive bladder cancer.系统筛选蛋白编码基因表达发现 HMMR 是肌层浸润性膀胱癌患者不良生存的潜在独立指标。
Biomed Pharmacother. 2019 Dec;120:109433. doi: 10.1016/j.biopha.2019.109433. Epub 2019 Sep 27.
6
Predicting tumor outcomes in urothelial bladder carcinoma: turning pathways into clinical biomarkers of prognosis.预测尿路上皮膀胱癌的肿瘤预后:将信号通路转化为预后的临床生物标志物
Expert Rev Anticancer Ther. 2008 Jul;8(7):1103-10. doi: 10.1586/14737140.8.7.1103.
7
Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles.基于定量基因表达谱预测初诊非浸润性乳头状膀胱癌的复发和进展。
Eur Urol. 2010 Jan;57(1):12-20. doi: 10.1016/j.eururo.2009.09.013. Epub 2009 Sep 9.
8
Cancer stem cell-specific expression profiles reveal emerging bladder cancer biomarkers and identify circRNA_103809 as an important regulator in bladder cancer.癌症干细胞特异性表达谱揭示了新的膀胱癌生物标志物,并鉴定出 circRNA_103809 是膀胱癌的一个重要调控因子。
Aging (Albany NY). 2020 Feb 17;12(4):3354-3370. doi: 10.18632/aging.102816.
9
Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?膀胱尿路上皮癌的分子标志物:我们是否已经达成目标?
Nat Rev Urol. 2011 Dec 13;9(1):41-51. doi: 10.1038/nrurol.2011.193.
10
Inhibition of tobacco smoke-induced bladder MAPK activation and epithelial-mesenchymal transition in mice by curcumin.姜黄素对烟草烟雾诱导的小鼠膀胱丝裂原活化蛋白激酶激活及上皮-间质转化的抑制作用。
Int J Clin Exp Pathol. 2015 May 1;8(5):4503-13. eCollection 2015.

引用本文的文献

1
Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis.LPAR6 和 CAB39L 的缺失会扰乱基底到腔上皮的尿路上皮分化程序,导致膀胱癌的发生。
Cell Rep. 2024 May 28;43(5):114146. doi: 10.1016/j.celrep.2024.114146. Epub 2024 Apr 25.
2
Molecular Oncology of Bladder Cancer from Inception to Modern Perspective.膀胱癌的分子肿瘤学:从起源到现代视角
Cancers (Basel). 2022 May 24;14(11):2578. doi: 10.3390/cancers14112578.
3
Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test.
新型多色荧光原位杂交(四重)检测法在尿液沉淀物中膀胱癌的检测。
Eur Urol Focus. 2019 Jul;5(4):664-675. doi: 10.1016/j.euf.2018.01.017. Epub 2018 Feb 7.
4
Urothelial tumors of the urinary bladder in young patients: a clinicopathologic study of 59 cases.年轻患者的膀胱尿路上皮肿瘤:59 例临床病理研究。
Arch Pathol Lab Med. 2013 Oct;137(10):1337-41. doi: 10.5858/arpa.2012-0322-OA.
5
The prevalence and prognostic significance of KRAS mutation in bladder cancer, chronic myeloid leukemia and colorectal cancer.KRAS 突变在膀胱癌、慢性髓性白血病和结直肠癌中的流行情况及其预后意义。
Mol Biol Rep. 2013 Jun;40(6):4109-14. doi: 10.1007/s11033-013-2512-8. Epub 2013 May 3.